Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 28;10(4):73.
doi: 10.3390/pharmacy10040073.

Investigation of Biomedical Students' Attitudes toward Pharmacogenomics and Personalized Medicine: A Cross-Sectional Study

Josipa Bukic  1 , Doris Rusic  1 , Dario Leskur  1 , Ana Seselja Perisin  1 , Tin Cohadzic  2 , Marko Kumric  3 , Josko Bozic  3 , Darko Modun  1
Affiliations

Investigation of Biomedical Students' Attitudes toward Pharmacogenomics and Personalized Medicine: A Cross-Sectional Study

Josipa Bukic et al. Pharmacy (Basel). .

Abstract

Background: The utilization of pharmacogenomics in everyday practice has shown several notable benefits. Keeping in mind the rising trend of applicability of pharmacogenomics and personalized medicine, we sought to compare the attitudes of future healthcare workers in different branches of the healthcare system.

Methods: The present study was conducted as a questionnaire-based cross-sectional study in October of 2020. Students eligible to participate were all the students of the University of Split School of Medicine enrolled in the academic year 2020/2021.

Results: The number of students that participated in the study was 503. Students were most interested in clinical examples of pharmacogenomics (31.4%) and the benefits of pharmacogenomics in clinical practice (36.4%). Furthermore, 72.6% of all students agreed that they should be able, in their future practice, to identify patients that could benefit from genetic testing.

Conclusion: At the present time, the lack of education and appropriate clinical guidelines appear to be the major barriers to the clinical application of pharmacogenomics, especially in Croatia. Hence, in order to support health care professionals' evidence-based therapeutic recommendations with patients' pharmacogenomic data, universities should offer more pharmacogenomics education in their curricula.

Keywords: attitudes; education; medicine; pharmacogenomics; pharmacy; students.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Anesh T.P., Sonal S., Jose A., Chandran L., Zachariah S.M. Pharmacogenomics: The right drug to the right person. J. Clin. Med. Res. 2009;1:191–194. - PMC - PubMed
    1. Vithanachchi D.T., Maujean A., Downes M.J., Scuffham P. A comprehensive review of economic evaluations of therapeutic drug monitoring interventions for cancer treatments. Br. J. Clin. Pharmacol. 2021;87:271–283. doi: 10.1111/bcp.14494. - DOI - PubMed
    1. Rohrer Vitek C.R., Abul-Husn N.S., Connolly J.J., Hartzler A.L., Kitchner T., Peterson J.F., Rasmussen L.V., Smith M.E., Stallings S., Williams M.S., et al. Healthcare provider education to support integration of phar, macogenomics in practice: The eMERGE Network experience. Pharmacogenomics. 2017;18:1013–1025. doi: 10.2217/pgs-2017-0038. - DOI - PMC - PubMed
    1. Whitley K.V., Tueller J.A., Weber K.S. Genomics Education in the Era of Personal Genomics: Academic, Professional, and Public Considerations. Int. J. Mol. Sci. 2020;21:768. doi: 10.3390/ijms21030768. - DOI - PMC - PubMed
    1. Gurwitz D., Lunshof J.E., Dedoussis G., Flordellis C.S., Fuhr U., Kirchheiner J., Licinio J., Llerena A., Manolopoulos V.G., Sheffield L.J., et al. Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education. Pharm. J. 2005;5:221–225. doi: 10.1038/sj.tpj.6500312. - DOI - PubMed

LinkOut - more resources